TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Mass balance recovery of total radioactivity in whole blood and plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mass balance recovery of total radioactivity in whole urine and feces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Local Skin Reaction (LSR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in hemoglobin A1c (HA1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maternal Thyroid volume measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Objective response (CR or PR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of smooth muscle cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of death, cardiac arrest, need for cardiac mechanical assist device, or re-hospitalization for heart failure
Endpoint domain: Mortality/survival
Primary endpoint: Occurrence of any thromboembolic event or death
Endpoint domain: Mortality/survival
Primary endpoint: Shoulder Pain Disability Index (SPADI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proportion of patients with upregulation of IL-6 or the IL-6 signalling pathway
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Patients Experiencing Treatment Emergent Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in poorly ventilated lung areas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Fall Percentage
Endpoint domain: Adverse events/effects
Primary endpoint: Change in clinical cognitive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Beta-hydoxybutyrate (BHB) Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of De Novo Lipogenesis (DNL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of Hepatic Steatosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of Resting Energy Expenditure (REE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: tumor shrinkage (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Error rate of the algorithm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in percent of lymphocyte cell surface expression markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in absolute number of lymphocyte cell surface expression markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in mean fluorescent intensity of lymphocyte cell surface expression markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improvement in Quality of Life - One Year Post Operatively
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Improvement in Quality of Life - Five Years Post Operatively
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Time to first unscheduled contact with acute asthma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with unscheduled care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of alarms responded to
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Likert response score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change of postural and sitting balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Subjects Who Are in Amenorrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Test of Everyday Attention for Children: Walk, Don't Walk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gordon Diagnostic System Continuous Performance Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wechsler Intelligence Scale for Children-IV, Digit Span Subtest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of Ulcerative Oral Mucositis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Plasma Concentration (Cmax) of Nicotinuric Acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Amount of Urinary Excretion of Niacin and Its Metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area Under Curve (AUC 0-infinity) of Laropiprant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Concentration (Cmax) of Laropiprant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of generic divalproex sodium extended release compared to Depakote ER
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reversibility of sickle cell vasculopathy and organ damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression to ventilation or sustained requirement of supplementary oxygen therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: modified Rankin Scale score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Successes (Subjects That Had no Inter-operative CSF Leak Following Valsalva Maneuver and no CSF Leak or Pseudomeningocele)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Fecal marker
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Use of opioids
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Extent of binocular vision at near working distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary performance endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analogue Scale (VAS) scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Parental self-efficacy scale scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Zarit care burden scale scores
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Perceived stress scale scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Family empowerment scale scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: RASS scale evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxycodone dosage for satisfactory analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum tolerated dose (MTD) of PS-341 in combination with Doxil
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rate of the combination of Velcade and Doxil
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Crohn's Disease Activity Index (CDAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma levels of cannabidiol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse Event Tracking
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of bile duct injuries
Endpoint domain: Adverse events/effects
Primary endpoint: mean cerebral blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change of the shaft-neck angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Displacement of the calcar segment in the lateral view
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Central placement of the femoral neck screw
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Structural White Matter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Average systolic 24-hour ambulatory blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Morning plasma ACTH levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Overall clinical well-being
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Ease of Using Clotting Factor Treatment Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Burden of Clotting Factor Treatment Score
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Overall Satisfaction Score With Refacto AF FuseNGO
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: diurnal rhythm of cortisol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: diurnal rhythm of ACTH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: baseline DHEAS level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: NYHA Heart Failure class
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of headache or migraine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Desaturation during surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Desaturation during early postoperative recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Psychopathology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of active TB disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Treatment Reactions Scale
Endpoint domain: Adverse events/effects
Primary endpoint: transition to psychosis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Progression of portal hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in mean daytime ABPM SBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Glycated Hemoglobin A1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Periodontal Pocket Probing Depth (PD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hamilton Depression Rating Scale for Depression (HAMD)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: IRLSS Score Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower Extremity subscale of Fugl-Meyer assessment (FMA-LE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Ashworth scale (MAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Activity Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Peritoneal dialysate effluent (PDE) white cell count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of participants requiring Tenckhoff catheter removal
Endpoint domain: Adverse events/effects
Primary endpoint: Mycological cure of target nail
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain activity in regions of interest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants Who Died Due to Adverse Events
Endpoint domain: Mortality/survival
Primary endpoint: Annualized Bleeding Rates (ABRs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anthropometric measurements change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance Questionnaire Scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overall response rate (complete + partial responses)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical response by day 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time Course Change in Functional Status Based on Karnofsky Performance Status Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of Participants Who Survived at 6 Months Following Completion of Plasma Exchange (PLEX)
Endpoint domain: Mortality/survival
Primary endpoint: fMRI BOLD signal differences
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants With Treatment Emergent Adverse Events Cumulative to Week 48 by Maximum Severity
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Post-baseline Local Tolerability Assessments Results by Treatment Group
Endpoint domain: Adverse events/effects
Primary endpoint: Subject and provider satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incident Type 2 Diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Echocardiography parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Electrocardiogram parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients taking uninterrupted HIV post-exposure prophylaxis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects experiencing treatment-related acute and late toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: inferior vena cava diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time left unprotected to venous thromboembolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Short-term cognitive changes after surgery
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Long-term cognitive changes after surgery
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of Participants With Clinical Response at the Test of Cure (TOC) Visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serologic Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: chest CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Finger pulse oxygen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: blood gas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: K-BILD
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Tolerated amount of milk protein (mg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy for INH and ETH resistance detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Diagnostic accuracy for fluoroquinolone resistance detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Diagnostic accuracy for second-line injectable resistance detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: change in Pink Esthetic Score (PES)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: State anxiety inventory (STAI) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Postprandial lipidemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cell cycle-related signature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expansion of T cell receptor (TCR) clones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Brief Pain Inventory (BPI) Interference Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Freedom from periprocedural Serious Adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Global Assessment of Functioning
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pain coping self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: number of patients with improved symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of myocardial infarction or cardiac death
Endpoint domain: Mortality/survival
Primary endpoint: Caregiver Burden Score
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Sustained Cell Engraftment of Donor Cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TV Viewing Time
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Work alliance inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Steady State Concentration (Css) for Estradiol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Steady State Concentration (Css) for Estrone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Steady State Concentration (Css) for Progesterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Unplanned hospital admission
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Eye blink response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peripheral Neuropathy Prevention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Safety of Cryotherapy
Endpoint domain: Adverse events/effects
Primary endpoint: Inadvertent obturator jerk prevention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Post-treatment VAS Score Averaged Daily Over 4 Weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weekly Foot Function Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Hair Density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Capsular contracture prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: differences in serum lipid levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: differences in regional and overall body fat level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: impacts on metabolic and cardiovascular health
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Accurate identification of bone metastases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: smokers' exposure to carcinogens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Duration of effect of Bimatoprost SR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Childhood obesity prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive and negative predictive value of circulating tumor DNA blood test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Acute cellular rejection after transplantation
Endpoint domain: Adverse events/effects
Primary endpoint: Percent reduction in liver endotoxin production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Maddrey's discriminant function (DF) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patients' adherence to medication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fluctuation in islet autoantibodies titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Functional Neural Activation Parameter Estimate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mortality at 30, 60, and 90 days
Endpoint domain: Mortality/survival
Primary endpoint: Intrahepatic progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Survival after TIVA vs sevoflurane anesthesia
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of recurrences
Endpoint domain: Mortality/survival
Primary endpoint: Death within 14 days after randomization
Endpoint domain: Mortality/survival
Primary endpoint: Major disability at 14 days or at hospital discharge
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Assessment of pain with questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: radiological markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first occurrence of composite endpoint
Endpoint domain: Mortality/survival
Primary endpoint: Duration of convalescence
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Peripheral tissue oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes